Erratum to: ‘Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial

Detalles Bibliográficos
Autores principales: Yardley, Denise A., Brufsky, Adam, Coleman, Robert E., Conte, Pierfranco F., Cortes, Javier, Glück, Stefan, Nabholtz, Jean-Mark A., O’Shaughnessy, Joyce, Beck, Robert M., Ko, Amy, Renschler, Markus F., Barton, Debora, Harbeck, Nadia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739389/
https://www.ncbi.nlm.nih.gov/pubmed/26841937
http://dx.doi.org/10.1186/s13063-016-1195-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739389/
https://www.ncbi.nlm.nih.gov/pubmed/26841937
http://dx.doi.org/10.1186/s13063-016-1195-6

Ejemplares similares